GO:0070346 positive regulation of fat cell proliferation: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070346 describes any process that activates or increases the rate or extent of fat cell (adipocyte) proliferation, a key step in adipose tissue expansion.
• EPAC1 (RAPGEF3) enhances brown fat growth and beige adipogenesis, directly linking cAMP signaling to positive regulation of fat cell proliferation.
• FTO, an m6A demethylase, promotes tumorigenesis and is associated with altered adipocyte biology, highlighting crosstalk between epitranscriptomics and fat cell proliferation.
• RUNX1T1 functions in cell fate decisions and can influence adipogenic differentiation, providing a model for studying proliferation versus differentiation.
• Metformin modulates adipogenic differentiation of mesenchymal stem cells, suggesting metabolic regulators can impact fat cell proliferation.
• CRISPR-based knockout, knock-in, and overexpression models are essential to dissect causal roles of genes in positive regulation of fat cell proliferation [2,3,8].
Description
Positive regulation of fat cell proliferation (GO:0070346) is a biological process that encompasses any molecular event that activates or increases the rate or extent of adipocyte proliferation. Adipocytes, or fat cells, are central to energy homeostasis, and their controlled expansion is critical for metabolic health. Dysregulated fat cell proliferation contributes to obesity, diabetes, and cancer progression, making this process a focal point for therapeutic intervention [2,3]. Understanding the signaling pathways and transcriptional networks that drive fat cell proliferation is therefore of paramount importance for researchers in metabolism, endocrinology, and oncology.
positive regulation of fat cell proliferation At A Glance
| GO ID | GO:0070346 |
|---|---|
| GO term | positive regulation of fat cell proliferation |
| Ontology | biological_process |
| Synonym | activation of fat cell proliferation; positive regulation of adipocyte proliferation; positive regulation of adipose cell proliferation; stimulation of fat cell proliferation; up regulation of fat cell proliferation; up-regulation of fat cell proliferation; upregulation of fat cell proliferation |
| Major function | Activates or increases the rate or extent of fat cell proliferation |
| Related processes | Adipogenesis, brown fat growth, beige adipogenesis, energy homeostasis |
| Key regulators | EPAC1 (RAPGEF3), FTO, RUNX1T1, metformin-responsive pathways |
What Is GO:0070346?
GO:0070346 is defined as any process that activates or increases the rate or extent of fat cell proliferation. In other words, it includes the signaling cascades, transcription factor activities, and epigenetic modifications that promote the division and expansion of adipocytes, whether in brown, beige, or white adipose tissue.
Why Is positive regulation of fat cell proliferation Important in Cell Biology?
Positive regulation of fat cell proliferation is fundamental to adipose tissue plasticity and whole-body energy balance. Its dysregulation is implicated in obesity, insulin resistance, and tumor microenvironment remodeling, where cancer-associated adipocytes can promote malignancy [2,3]. Moreover, brown and beige adipocytes, which arise from proliferating precursors, are promising targets for anti-obesity therapies. Thus, deciphering the molecular players that positively regulate fat cell proliferation offers opportunities for therapeutic intervention in metabolic and neoplastic diseases.
• Controls adipose tissue expansion in response to nutritional and hormonal cues.
• Impacts energy expenditure through brown and beige adipocyte recruitment.
• Dysregulated in obesity and type 2 diabetes, contributing to metabolic dysfunction.
• Modulated by epigenetic factors such as FTO, linking m6A modification to adipocyte biology.
• Influenced by transcription factors like RUNX1T1 that govern cell fate decisions.
• Potential target for anti-obesity and anti-diabetic therapeutics [2,6].
• Relevant to cancer progression, as tumor cells can induce adipocyte proliferation.
• Studied using CRISPR screens to identify novel regulators [2,3,8].
What Happens During positive regulation of fat cell proliferation?
Initiation by Growth Factors and Hormones
In simple terms: Signals from outside the cell tell fat precursor cells to start dividing.
Positive regulation of fat cell proliferation begins when extracellular cues, such as growth factors, hormones, or nutrients, bind to cell surface receptors. For example, EPAC1, a cAMP sensor, enhances brown fat growth and beige adipogenesis, indicating that cAMP signaling positively regulates fat cell proliferation. These signals activate intracellular cascades that ultimately drive cell cycle entry.
Intracellular Signaling Cascades
In simple terms: Inside the cell, a relay of proteins passes the message to the nucleus.
Following receptor activation, second messengers like cAMP activate downstream effectors. EPAC1 (encoded by RAPGEF3) is directly activated by cAMP and promotes brown fat growth and beige adipogenesis, demonstrating its role in positive regulation of fat cell proliferation. Other pathways, such as those involving RUNX1T1, influence cell fate decisions that can favor proliferation over differentiation.
Transcriptional and Epigenetic Control
In simple terms: The cell's command center turns specific genes on or off to drive division.
Signaling cascades converge on transcription factors and epigenetic modifiers that reprogram gene expression. FTO, an m6A demethylase, modulates RNA methylation and affects adipocyte biology; its inhibition suppresses tumorigenesis and may alter fat cell proliferation in the tumor microenvironment. RUNX1T1 acts as a transcriptional corepressor that can influence adipogenic differentiation and proliferation.
Metabolic and Pharmacological Modulation
In simple terms: Drugs and metabolic states can boost or block fat cell proliferation.
Metformin, a widely used anti-diabetic drug, potentiates adipogenic differentiation of human umbilical cord-mesenchymal stem cells, suggesting that metabolic regulators can impact fat cell proliferation. Additionally, berberine inhibits high-fat-diet-associated colorectal cancer through modulation of gut microbiota and lysophosphatidylcholine, indirectly affecting adipose tissue biology.
Key Genes Involved in GO:0070346 positive regulation of fat cell proliferation
The following genes have been experimentally linked to positive regulation of fat cell proliferation or related adipogenic processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAPGEF3 (EPAC1) | cAMP sensor that enhances brown fat growth and beige adipogenesis | Direct positive regulator of fat cell proliferation; knockout models show reduced brown fat |
| FTO | m6A demethylase affecting RNA methylation | Inhibition suppresses tumorigenesis and may modulate adipocyte proliferation |
| RUNX1T1 | Transcriptional corepressor in cell fate decisions | Influences adipogenic differentiation and proliferation |
| DMBT1 | Exosomal protein from urine-derived stem cells | Promotes angiogenesis in diabetic wound repair; may indirectly affect adipose tissue |
| FTO | Epitranscriptomic regulator | Linked to obesity and cancer; potential target for modulating fat cell proliferation |
| RAPGEF3 | Guanyl nucleotide exchange factor | Key mediator of cAMP-induced brown fat growth |
| RUNX1T1 | RUNX1 translocation partner | Fusion protein in leukemia; role in adipogenesis |
| FTO | Alpha-ketoglutarate-dependent dioxygenase | Demethylates m6A in mRNAs; affects adipocyte biology |
| RAPGEF3 | EPAC1 | Activates Rap1; promotes beige adipogenesis |
| RUNX1T1 | ETO | Corepressor; modulates transcription factors in adipogenesis |
| FTO | Fat mass and obesity-associated protein | GWAS locus for obesity; affects fat cell proliferation |
| RAPGEF3 | cAMP-regulated GEF | Potential drug target for obesity |
| RUNX1T1 | MTG8 | Involved in t(8;21) leukemia; may influence adipose lineage |
| FTO | m6A demethylase | Small molecule inhibitors under development |
| RAPGEF3 | EPAC1 | Studied in brown/beige adipocyte recruitment |
| RUNX1T1 | ETO2 | Cell fate regulator; knockout affects adipogenesis |
How Is positive regulation of fat cell proliferation Regulated?
Positive regulation of fat cell proliferation is controlled by a network of signaling pathways, including cAMP-EPAC1 signaling, which enhances brown fat growth and beige adipogenesis. Epigenetic modifiers such as FTO modulate RNA methylation and can influence adipocyte proliferation. Transcription factors like RUNX1T1 integrate developmental cues to balance proliferation and differentiation. Pharmacological agents such as metformin can also modulate adipogenic differentiation, suggesting metabolic regulation of this process.
positive regulation of fat cell proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RAPGEF3 | Obesity, brown fat deficiency | Knockout mouse, overexpression in adipocytes |
| FTO | Hepatocellular carcinoma, obesity | CRISPR knockout in cancer cell lines, point mutation |
| RUNX1T1 | Leukemia, adipogenesis disorders | Knock-in of fusion protein, knockout |
| DMBT1 | Diabetic wound healing | Exosome treatment in diabetic models |
| Metformin targets | Type 2 diabetes | Adipogenic differentiation assays |
Obesity and Metabolic Syndrome
Dysregulated positive regulation of fat cell proliferation contributes to adipose tissue expansion in obesity. EPAC1-mediated brown fat growth is a potential target for increasing energy expenditure and combating obesity. Metformin's effects on adipogenic differentiation highlight the interplay between anti-diabetic drugs and fat cell proliferation.
Cancer and Tumor Microenvironment
FTO, an m6A demethylase, promotes tumorigenesis in hepatocellular carcinoma and may influence adipocyte proliferation in the tumor microenvironment. Berberine inhibits high-fat-diet-associated colorectal cancer through gut microbiota modulation, indirectly affecting adipose tissue.
Diabetes and Wound Healing
Exosomal DMBT1 from urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis, a process that may involve adipose tissue remodeling. RUNX1T1's role in cell fate decisions could impact adipose regeneration in diabetes.
From positive regulation of fat cell proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does EPAC1 promote fat cell proliferation? | RAPGEF3 knockout and overexpression in brown preadipocytes |
| Does FTO inhibition affect adipocyte proliferation? | FTO knockout or point mutation in adipocyte cell lines |
| What is the role of RUNX1T1 in adipogenesis? | RUNX1T1 knockout and knock-in in mesenchymal stem cells |
| Can metformin modulate fat cell proliferation? | Metformin treatment in human umbilical cord-mesenchymal stem cells |
| Does DMBT1 affect adipose tissue remodeling? | Exosomal DMBT1 treatment in diabetic wound models |
| Does berberine influence fat cell proliferation via microbiota? | High-fat diet mouse models with berberine |
How to Study the positive regulation of fat cell proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Loss-of-function effects on proliferation | Identify positive regulators [2,3,8] |
| RNA-seq | Transcriptional changes | Profile gene expression during adipocyte proliferation |
| m6A-seq | RNA methylation sites | Study FTO-mediated epitranscriptomics |
| EdU incorporation | DNA synthesis | Quantify proliferating fat cells |
| Ki-67 staining | Proliferation marker | Assess cell cycle entry |
| Western blot | Protein expression | Validate knockout/overexpression |
| Mouse adipose histology | Adipose tissue morphology | Evaluate brown/beige fat expansion |
| Exosome isolation | Extracellular vesicles | Study DMBT1-mediated effects |
CRISPR Screens for Regulators
Genome-wide CRISPR knockout screens can identify genes that positively regulate fat cell proliferation. For example, targeting RAPGEF3, FTO, or RUNX1T1 in adipocyte precursors followed by proliferation assays can reveal their causal roles [2,3,8].
Transcriptomic and Epitranscriptomic Profiling
RNA-seq and m6A-seq can uncover transcriptional and epitranscriptomic changes during fat cell proliferation. FTO's demethylase activity affects m6A levels, which can be mapped to identify target transcripts.
Proliferation Assays
EdU incorporation, Ki-67 staining, and cell counting are standard methods to measure fat cell proliferation. These assays can be applied to cells with genetic modifications in candidate genes [2,6].
In Vivo Adipose Tissue Analysis
Mouse models with adipose-specific knockout or overexpression of genes like RAPGEF3 can be used to assess brown fat growth and beige adipogenesis in vivo.
How CRISPR Can Be Used to Study GO:0070346 positive regulation of fat cell proliferation
Knockout
CRISPR knockout of candidate genes such as RAPGEF3, FTO, or RUNX1T1 in adipocyte precursors can determine whether they are required for fat cell proliferation. For instance, RAPGEF3 knockout reduces brown fat growth.
Point Mutation
Introducing point mutations in catalytic residues of FTO or EPAC1 can dissect the importance of enzymatic activity in positive regulation of fat cell proliferation [2,3].
Knock-in
Knock-in of tagged versions of RUNX1T1 or RAPGEF3 allows for localization and interaction studies in adipocytes.
Overexpression
Overexpression of EPAC1 or FTO in adipocyte cell lines can test sufficiency for promoting fat cell proliferation [2,3].
How EDITGENE Supports positive regulation of fat cell proliferation Research
Researchers studying positive regulation of fat cell proliferation-related genes often need to determine whether a candidate gene is causally involved in adipocyte expansion. EDITGENE provides comprehensive CRISPR services to accelerate this discovery.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of fat cell proliferation research.
Frequently Asked Questions About positive regulation of fat cell proliferation
What is positive regulation of fat cell proliferation?
It is any process that activates or increases the rate or extent of fat cell proliferation, as defined by GO:0070346.
What genes are involved in positive regulation of fat cell proliferation?
Key genes include RAPGEF3 (EPAC1), FTO, and RUNX1T1, among others [2,3,8].
How does EPAC1 regulate fat cell proliferation?
EPAC1, encoded by RAPGEF3, is a cAMP sensor that enhances brown fat growth and beige adipogenesis.
What is the role of FTO in fat cell proliferation?
FTO is an m6A demethylase that modulates RNA methylation and can influence adipocyte biology and tumorigenesis.
Can metformin affect fat cell proliferation?
Metformin potentiates adipogenic differentiation of mesenchymal stem cells, suggesting it can modulate fat cell proliferation.
What diseases are associated with dysregulated fat cell proliferation?
Obesity, type 2 diabetes, and cancer are linked to altered fat cell proliferation [2,3,6].
How can I study positive regulation of fat cell proliferation?
Use CRISPR knockout, overexpression, RNA-seq, and proliferation assays in adipocyte models [2,3,8].
What is the GO ID for positive regulation of fat cell proliferation?
The GO ID is GO:0070346.
What are synonyms for positive regulation of fat cell proliferation?
Synonyms include activation of fat cell proliferation, positive regulation of adipocyte proliferation, and stimulation of fat cell proliferation.
Why is positive regulation of fat cell proliferation important?
It controls adipose tissue expansion and energy balance, with implications for obesity, diabetes, and cancer [2,3].
Conclusion
Positive regulation of fat cell proliferation (GO:0070346) is a critical biological process that governs adipose tissue expansion and metabolic health. Key regulators such as EPAC1, FTO, and RUNX1T1 have been identified through molecular studies, offering potential therapeutic targets for obesity, diabetes, and cancer [2,3,8]. Continued research using CRISPR-based models and advanced profiling techniques will further unravel the complex signaling networks that control fat cell proliferation.
References
- 2. Reverte-Salisa L et al.. 2024. EPAC1 enhances brown fat growth and beige adipogenesis.. Nat Cell Biol 26(1):113-123 PMID: 38195707
- 3. Chen A et al.. 2024. Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma.. Gut 74(1):90-102 PMID: 38839271
- 4. Chen CY et al.. 2018. Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis.. Theranostics 8(6):1607-1623 PMID: 29556344
- 5. Chen H et al.. 2023. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine.. Int J Biol Sci 19(7):2097-2113 PMID: 37151876
- 6. Bajetto A et al.. 2023. Metformin potentiates immunosuppressant activity and adipogenic differentiation of human umbilical cord-mesenchymal stem cells.. Int Immunopharmacol 124(Pt B):111078 PMID: 37844465
- 8. Hu N et al.. 2022. RUNX1T1 function in cell fate.. Stem Cell Res Ther 13(1):369 PMID: 35902872
